JP2016512248A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512248A5
JP2016512248A5 JP2016500370A JP2016500370A JP2016512248A5 JP 2016512248 A5 JP2016512248 A5 JP 2016512248A5 JP 2016500370 A JP2016500370 A JP 2016500370A JP 2016500370 A JP2016500370 A JP 2016500370A JP 2016512248 A5 JP2016512248 A5 JP 2016512248A5
Authority
JP
Japan
Prior art keywords
dosage form
administered
subject
crushed
solid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016500370A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/018101 external-priority patent/WO2014149397A1/en
Publication of JP2016512248A publication Critical patent/JP2016512248A/ja
Publication of JP2016512248A5 publication Critical patent/JP2016512248A5/ja
Withdrawn legal-status Critical Current

Links

Images

JP2016500370A 2013-03-15 2014-02-24 食事に関係なく投与され得る、痛覚消失の急速な開始および期間の延長のためのオピオイドおよびさらなる活性医薬成分を含む組成物 Withdrawn JP2016512248A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201361798525P 2013-03-15 2013-03-15
US201361794848P 2013-03-15 2013-03-15
US61/798,525 2013-03-15
US61/794,848 2013-03-15
US201361871690P 2013-08-29 2013-08-29
US61/871,690 2013-08-29
US201361871956P 2013-08-30 2013-08-30
US61/871,956 2013-08-30
US201461926027P 2014-01-10 2014-01-10
US61/926,027 2014-01-10
US201461928509P 2014-01-17 2014-01-17
US61/928,509 2014-01-17
PCT/US2014/018101 WO2014149397A1 (en) 2013-03-15 2014-02-24 Compositions comprising an opioid and an additional active pharmaceutical ingredient for rapid onset and extended duration of analgesia that may be administered without regard to food

Publications (2)

Publication Number Publication Date
JP2016512248A JP2016512248A (ja) 2016-04-25
JP2016512248A5 true JP2016512248A5 (enExample) 2017-03-30

Family

ID=50290266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500370A Withdrawn JP2016512248A (ja) 2013-03-15 2014-02-24 食事に関係なく投与され得る、痛覚消失の急速な開始および期間の延長のためのオピオイドおよびさらなる活性医薬成分を含む組成物

Country Status (7)

Country Link
US (1) US20140275143A1 (enExample)
EP (1) EP2968169A1 (enExample)
JP (1) JP2016512248A (enExample)
CN (1) CN105209021A (enExample)
BR (1) BR112015022567A2 (enExample)
CA (1) CA2903200A1 (enExample)
WO (1) WO2014149397A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations
RU2015138422A (ru) 2009-07-22 2018-12-25 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
NZ607392A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising inorganic salt
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
RS56527B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
DK2838512T3 (en) 2012-04-18 2018-11-19 Gruenenthal Gmbh MANIPULATED AND DOSAGE DUMPED PHARMACEUTICAL DOSAGE FORM
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
MX2017013643A (es) * 2015-04-24 2018-03-08 Gruenenthal Gmbh Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US9943513B1 (en) 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
US10335405B1 (en) 2016-05-04 2019-07-02 Patheon Softgels, Inc. Non-burst releasing pharmaceutical composition
WO2017196445A1 (en) * 2016-05-11 2017-11-16 Relmada Therapeutics, Inc. Abrasion-resistant opioid formulations
US10335375B2 (en) 2017-05-30 2019-07-02 Patheon Softgels, Inc. Anti-overingestion abuse deterrent compositions
CN109512796A (zh) * 2018-12-26 2019-03-26 甘肃普安制药股份有限公司 一种氨酚羟考酮胶囊填充方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092724A1 (en) * 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
US8377453B2 (en) * 2008-03-11 2013-02-19 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8597681B2 (en) * 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8658631B1 (en) * 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia

Similar Documents

Publication Publication Date Title
JP2014240439A5 (enExample)
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
JP2018162255A5 (enExample)
ZA202303338B (en) Orodispersible dosage unit containing an estetrol component
JP2013520405A5 (enExample)
JP2012012418A5 (enExample)
JP2013505205A5 (enExample)
JP2016512247A5 (enExample)
JP2013520167A5 (enExample)
JP2012136541A5 (enExample)
WO2015120110A3 (en) Novel pharmaceutical formulations
JP2016534153A5 (enExample)
JP2015517488A5 (enExample)
JP2017503014A5 (enExample)
JP2016510326A5 (enExample)
JP2018527305A5 (enExample)
HK1222563A1 (zh) 药物组合物、制备及其用途
HK1245086A1 (zh) 处方药物组成及其制备和使用
JP2017512194A5 (enExample)
JP2017507142A5 (enExample)
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
JP2015531749A5 (enExample)
WO2016040814A3 (en) Disulfide polymers and methods of use
JP2017519762A5 (enExample)
JP2017514858A5 (enExample)